Fungispecificity of fluconazole against Candida albicans

[1]  F. Daschner,et al.  Sensitivity testing with ketoconazole in an assay containingCandida albicans, human polymorphonuclear leukocytes and serum , 1986, European Journal of Clinical Microbiology.

[2]  M. Saag,et al.  Azole antifungal agents: emphasis on new triazoles , 1988, Antimicrobial Agents and Chemotherapy.

[3]  J. Galgiani,et al.  Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivo , 1986, Antimicrobial Agents and Chemotherapy.

[4]  L. V. Hill,et al.  Vaginitis: current microbiologic and clinical concepts. , 1986, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[5]  A. Sugar,et al.  Comparative activities of UK-49,858 and amphotericin B against Blastomyces dermatitidis infections in mice , 1986, Antimicrobial Agents and Chemotherapy.

[6]  P. Troke,et al.  Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice , 1985, Antimicrobial Agents and Chemotherapy.

[7]  M J Humphrey,et al.  Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans , 1985, Antimicrobial Agents and Chemotherapy.

[8]  J. Sobel.  Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. , 1985, American journal of obstetrics and gynecology.

[9]  P. Troke,et al.  Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes , 1985, Antimicrobial Agents and Chemotherapy.

[10]  F. Odds.  Ecology and epidemiology of Candida species. , 1984, Zentralblatt für Bakteriologie Mikrobiologie und Hygiene Series A Medical Microbiology Infectious Diseases Virology Parasitology.

[11]  M. Cohen,et al.  Host defences and the vaginal mucosa. A re-evaluation. , 1984, Scandinavian journal of urology and nephrology. Supplementum.

[12]  K. Holmes,et al.  Bacteriology of the vagina. , 1984, Scandinavian journal of urology and nephrology. Supplementum.

[13]  R. D. King,et al.  Characterization of Candida albicans adherence to human vaginal epithelial cells in vitro , 1983, Infection and immunity.

[14]  E. Segal,et al.  In vitro and in vivo adherence of Candida albicans to mucosal surfaces. , 1983, Annales de microbiologie.

[15]  V. Sutter.  Frequency of occurrence and antimicrobial susceptibility of bacterial isolates from the intestinal and female genital tracts. , 1983, Reviews of infectious diseases.

[16]  D. Eschenbach.  Vaginal infection. , 1983, Clinical obstetrics and gynecology.

[17]  R. Galask,et al.  Vaginal microbial flora: composition and influences of host physiology. , 1982, Annals of internal medicine.

[18]  L. Samaranayake,et al.  The adhesion of the yeast Candida albicans to epithelial cells of human origin in vitro. , 1981, Archives of oral biology.

[19]  L. Montes,et al.  Scanning electron microscopy of oral lesions in chronic mucocutaneous candidiasis. , 1980, JAMA.

[20]  C. Squier,et al.  Candida albicans ultrastructure: colonization and invasion of oral epithelium. , 1980, Infection and immunity.

[21]  R. Galask,et al.  Vaginal Microbial Flora: Practical and Theoretic Relevance , 1980, Obstetrics and gynecology.

[22]  R. D. King,et al.  Adherence of Candida albicans and other Candida species to mucosal epithelial cells , 1980, Infection and immunity.

[23]  P. Hoeprich,et al.  Obfuscation of the activity of antifungal antimicrobics by culture media. , 1972, The Journal of infectious diseases.